The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
FENETHAZINE ID: ALA2106299
Chembl Id: CHEMBL2106299
Cas Number: 522-24-7
PubChem CID: 68223
Max Phase: Phase
Molecular Formula: C16H18N2S
Molecular Weight: 270.40
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Synonyms: Phenethazine | Fenethazine|Phenethazine|522-24-7|Fenethazine [INN:DCF]|N,N-dimethyl-2-phenothiazin-10-ylethanamine|10-(2-Dimethylaminoethyl)phenothiazine|8J97CUZ4HX|Phenetazine|Phenethazinum|Rutergan|Etisin|Fenethazine (INN)|RP 3015; Rutergan; SC 1627|Anergell|Anergen|Ethizine|Ethysene|Ethysine|Ethyzine|Etisine|Lisergan|Lysergan|FENETHAZINE [INN]|Fenetazina [DCIT]|N,N-dimethyl-2-(10H-phenothiazin-10-yl)ethan-1-amine|Fenethazinum|Fenethazinum [INN-Latin]|EINECS 208-325-1|UNII-8J97CUZ4HX|RP 3015|S Show More⌵
Canonical SMILES: CN(C)CCN1c2ccccc2Sc2ccccc21
Standard InChI: InChI=1S/C16H18N2S/c1-17(2)11-12-18-13-7-3-5-9-15(13)19-16-10-6-4-8-14(16)18/h3-10H,11-12H2,1-2H3
Standard InChI Key: PFAXACNYGZVKMX-UHFFFAOYSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: YesAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 270.40Molecular Weight (Monoisotopic): 270.1191AlogP: 3.85#Rotatable Bonds: 3Polar Surface Area: 6.48Molecular Species: BASEHBA: 3HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 2HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 8.76CX LogP: 3.87CX LogD: 2.50Aromatic Rings: 2Heavy Atoms: 19QED Weighted: 0.84Np Likeness Score: -1.11
References 1. USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date, 2. Dai XJ, Zhao LJ, Yang LH, Yang LH, Guo T, Xue LP, Ren HM, Yin ZL, Xiong XP, Zhou Y, Ji SK, Liu HM, Liu HM, Liu Y, Zheng YC.. (2023) Phenothiazine-Based LSD1 Inhibitor Promotes T-Cell Killing Response of Gastric Cancer Cells., 66 (6): [PMID:36856685 ] [10.1021/acs.jmedchem.2c01593 ]